Eur J Pharmacol 875:173040 Lee DM, Battson ML, Jarrell DK, Hou S, Ecton KE, Weir TL, Gentile CL (2018) SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Liraglutide, Semaglutide, and Tirzepatide are well-studied glucagon-like peptide 1 (GLP-1) agonists that may be used as an option for patients needing assistance with metabolic issues and improving body composition
Neuroproteccin: Puede proteger las neuronas de los daos causados por las enfermedades neurodegenerativas y los accidentes cerebrovasculares
Modifications in intestinal microbial structure compromise barrier integrity, facilitating bacterial product migration into the portal circulation
Coverage depends on the members plan
"NRF2-Driven KEAP1 Transcription in Human Lung Cancer"